Dr. James W. Lee
Claim this profileVirtua Samson Cancer Center
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
17 reported clinical trials
26 drugs studied
About James W. Lee
Education:
- Earned an MD from Cornell University Medical College.
Experience:
- Board Certified in Internal Medicine and Oncology.
- Has over 30 years of experience in patient care.
- Joined Hematology Oncology Associates, SJ in 2004, serving the Mount Holly community.
- Completed an internship at Georgetown University Hospital and received training at the National Cancer Institute (NCI).
- Actively participates in clinical trials to advance cancer diagnosis and treatment techniques.
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials James W. Lee is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about James W. Lee
Clinical Trial Related4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments James W. Lee has experience with
- Pembrolizumab
- Carboplatin
- Ramucirumab
- Pemetrexed
- Selpercatinib
- Pemetrexed Disodium
Breakdown of trials James W. Lee has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James W. Lee specialize in?
James W. Lee focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is James W. Lee currently recruiting for clinical trials?
Yes, James W. Lee is currently recruiting for 7 clinical trials in Moorestown New Jersey. If you're interested in participating, you should apply.
Are there any treatments that James W. Lee has studied deeply?
Yes, James W. Lee has studied treatments such as Pembrolizumab, Carboplatin, Ramucirumab.
What is the best way to schedule an appointment with James W. Lee?
Apply for one of the trials that James W. Lee is conducting.
What is the office address of James W. Lee?
The office of James W. Lee is located at: Virtua Samson Cancer Center, Moorestown, New Jersey 08057 United States. This is the address for their practice at the Virtua Samson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.